Partner & Patent Attorney

Manchester Office

Telephone. +44(0) 161 247 4900
Mobile. +44(0) 746 923 8960
Email. [email protected]


Iain’s practice focuses on patent prosecution in the life sciences field. A cell biologist by background, he has particular experience in medical applications of the life sciences. His interests cover a number of challenging legal and technical areas, including: cell-based therapies (such as CAR-T and stem cells); personalised healthcare; therapeutic antibodies; wound healing therapies; and cancer treatments.

His client base ranges from start-ups to multinationals, with a particular focus on university research and technology transfer. He counts a number of highly regarded UK and overseas universities among his clients and is a member of the Association of University Technology Managers (regularly attending the AUTM Annual Meeting).

Iain aims to provide clear and pragmatic advice to his clients, guiding them through complex legal issues, and helping them use the patent system to meet their business aims. Having been in private practice for over 20 years, Iain has extensive experience in the development, growth and management of biotech-based patent portfolios. He has demonstrated expertise in drafting and prosecution of patent applications suitable for worldwide coverage, and able to provide high quality protection that stands up to competitor challenge or rigorous due diligence. He is familiar with many of the technical and legal problems that can arise in this complicated area, and with counselling clients through these.

Iain has been invited to speak on topics including: "Biotech patent drafting", "Patentability of stem cells” and “CAR-T cell therapy: filing trends, opportunities and challenges to patentability”.


  • Cell and gene therapy
  • Diagnostics
  • Immunobiology
  • Personalised medicine


  • Healthcare icon Healthcare
  • Pharmaceuticals icon Pharmaceuticals


  • Due diligence
  • Patents
  • Portfolio management
  • Strategy


Patent Attorney

Chartered (UK)


First class (Honours) Cell Biology - University of Glasgow


Postgraduate Certificate in Intellectual Property - University of Manchester


Immunotherapy patents: Why CAR-T is driving up patent activity

View publication online

Conferences: 2021

June 14th 2021

BIO International Convention


Conferences: 2020

November 4th 2020

Bionow Oncology Conference 2020


Event details

Conferences: 2019

October 16th 2019

Life Sciences Patent Network North America 2019 - San Francisco


Event details


Member of CIPA’s Life Sciences Committee

Produced CIPA CPD lecture on “Biotech patent drafting”

Produced CIPA CPD lecture on “Patentability of stem cells”

Related News

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article
Event - 9th June 2021

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …

Event details
Event - 25th May 2021

IAM webinar: How to capitalise on the 5G healthcare revolution

HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.